R2 Ventures

R2 Ventures is a venture capital firm that invests in early-stage companies across technology, healthcare, and digitally enabled industries. The firm focuses on backing founders developing transformative solutions with strong long-term potential, supporting them from initial traction through meaningful early growth. R2 Ventures maintains a flexible investment strategy and has participated in rounds ranging from early seed to larger Series A financings. Its portfolio includes companies such as Superfiliate, Delix Therapeutics, and Paladin — spanning sectors like digital commerce, biotech, and cybersecurity. These investments reflect the firm’s interest in innovative, high-impact technologies capable of reshaping their respective markets. Beyond providing capital, R2 Ventures aims to support founders with strategic guidance and a network of operators, industry experts, and co-investors. The firm’s approach centers on partnering closely with entrepreneurs to help them scale efficiently and prepare for subsequent stages of growth.